Other News To Note
Wednesday, October 19, 2011
NeurOp Inc., of Atlanta, was selected to participate in the 2011-2012 Commercialization Assistance Program (CAP) funded by the National Institutes of Health. The company is looking to CAP to help it refine a commercialization plan for its ischemia drug program.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.